Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. brain surgery
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Brain Surgery Articles & Analysis: Older

38 news found

Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Planning brain surgery is a delicate process that requires precision to avoid damaging surrounding brain tissue and to prevent post-surgery complications. ...

BySynaptive Medical


Anuncia Medical Announces First Successful US Implant of the Company’s ReFlow Device with Sonolucent Cranial Plate to Noninvasively Visualize Flushing of Hydrocephalus Shunts

Anuncia Medical Announces First Successful US Implant of the Company’s ReFlow Device with Sonolucent Cranial Plate to Noninvasively Visualize Flushing of Hydrocephalus Shunts

(“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF) management systems, is pleased to announce the successful first implant of the Company’s FDA-cleared ReFlow™ Mini Flusher device in tandem with a “sonolucent” cranial plate (Clearfit® Cover, Longeviti, Baltimore ...

ByAnuncia Medical, Inc.


Intermountain Primary Children’s Hospital First in Nation to Successfully Implant New Brain Shunt Accessory for Patients with Hydrocephalus

Intermountain Primary Children’s Hospital First in Nation to Successfully Implant New Brain Shunt Accessory for Patients with Hydrocephalus

This extra fluid puts pressure on the brain and can cause brain damage. Hydrocephalus is characterized by head enlargement in infants. ...

ByAnuncia Medical, Inc.


Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow Mini Flusher Device for Hydrocephalus Patients

Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow Mini Flusher Device for Hydrocephalus Patients

Performed by neurosurgeon Samuel Cheshier, MD, at Intermountain Primary Children’s Hospital in Salt Lake City, the patient previously required at least 11 brain surgeries to manage their hydrocephalus, a chronic neurological condition in which excess CSF accumulates in the brain, often causing severe symptoms, frequent hospitalizations, and ...

ByAnuncia Medical, Inc.


7-year-old Boy Managing His Hydrocephalus with ReFlow Ventricular System “Gen 1” Featured on Charleston’s ABC News 4

7-year-old Boy Managing His Hydrocephalus with ReFlow Ventricular System “Gen 1” Featured on Charleston’s ABC News 4

After struggling to conceive a child for what felt like ages, Miranda of Moncks County, South Carolina finally fell pregnant - a miracle that quickly turned into horror when she delivered at 24 weeks in late 2015. At just 1 pound and 12 ounces, her son, Sutton, arrived with life-threatening health issues, including hydrocephalus - a neurological disorder caused by an abnormal buildup of ...

ByAnuncia Medical, Inc.


Anuncia Medical, Inc., receives FDA clearance for the ReFlow System Mini for the treatment of patients with hydrocephalus

Anuncia Medical, Inc., receives FDA clearance for the ReFlow System Mini for the treatment of patients with hydrocephalus

Our efforts to evolve hydrocephalus care will continue with clinical trials to evaluate the potential of Mini to extend shunt life and significantly reduce the large unmet medical need of solving repeat revision brain surgeries.” In addition, this week Anuncia Medical was honored by AZBio as a “2022 Fast Lane Company for the progress they are making ...

ByAnuncia Medical, Inc.


LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures

LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures

The clinical use of this product is expected to enhance bone healing, reduce infection rates, and improve the cosmetic outcome of these procedures for patients while eliminating the need for metal fixation hardware. Brain surgery often involves performing a craniotomy, a procedure by which a portion of the skull is temporarily removed using bone cutting ...

ByRevBio Inc.


The next evolution in blood vessel occlusion

The next evolution in blood vessel occlusion

A lower extremity bypass procedure - like any surgery - can be more difficult as we age. The bad news was that the best veins for the procedure - which involves grafting a vein from another part of the body to bypass her blocked arteries in the leg - were unusable. ...

ByAmsel Medical Corporation


Synchron Announces First Human U.S. Brain-Computer Interface Implant

Synchron Announces First Human U.S. Brain-Computer Interface Implant

Synchron, an endovascular brain-computer interface (BCI) company, today announced the first human BCI implant in the United States. This procedure represents a significant technological milestone for scalable BCI devices and is the first to occur in the U.S. using an endovascular BCI approach, which does not require invasive open-brain surgery. ...

BySynchron, Inc.


Synchron Appoints Kurt Haggstrom as Chief Commercial Officer

Synchron Appoints Kurt Haggstrom as Chief Commercial Officer

Synchron, an endovascular brain-computer (BCI) interface company, today announced the appointment of Kurt Haggstrom as Chief Commercial Officer. ...

BySynchron, Inc.


Team Gleason Partners with Synchron to Redefine Accessibility

Team Gleason Partners with Synchron to Redefine Accessibility

“We’re excited to announce our partnership with Team Gleason, who will assist our team in increasing awareness of endovascular BCI technology that does not require open brain surgery,” said Tom Oxley, M.D., CEO & Founder, Synchron. ...

BySynchron, Inc.


Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis

Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis

The Stentrode is implanted to the motor cortex of the brain through the jugular vein in a minimally-invasive procedure. Once implanted, it translates brain activity into a standardized digital language to allow patients to complete everyday tasks hands-free, on external devices including texting, emailing, online shopping and accessing telehealth services. ...

BySynchron, Inc.


Synchron Announces Long-Term Safety Results from Fully Implanted Endovascular Brain-Computer Interface Stentrode for Severe Paralysis

Synchron Announces Long-Term Safety Results from Fully Implanted Endovascular Brain-Computer Interface Stentrode for Severe Paralysis

Four Patients With ALS Who Received Stentrode™ Implant Gained Ability to Perform Daily Online Tasks No Serious Adverse Events Reported after 12 Months Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ device, a small mesh-like ...

BySynchron, Inc.


NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®

NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®

It is widely recognized that alternatives to antiepileptic drugs (AEDs) and surgery are a significant unmet medical need, especially for patients with incomplete seizure control who may not be candidates for, or wish to avoid the risks of, surgery and implantable devices. ...

ByNeuroSigma, Inc.


Synchron Expands Advisory Board as Brain-Computer Interface Device Stentrode Advances into Patients in US Clinical Trials

Synchron Expands Advisory Board as Brain-Computer Interface Device Stentrode Advances into Patients in US Clinical Trials

” Synchron has developed an endovascular brain computer interface that is designed to access every corner of the brain using its natural highways, the blood vessels. ...

BySynchron, Inc.


AI ‘Fingerprinting’ Fights Back Against Hard-to-Detect Cancers

AI ‘Fingerprinting’ Fights Back Against Hard-to-Detect Cancers

Reveal Surgical is working on changing that reality through its new, AI-based Sentry technology, which leverages a combination of AI and Raman spectroscopy to provide real-time tissue diagnostics during surgery for otherwise-invisible tumors. Raman spectroscopy is the use of light scattering from a laser to detect molecular structures and compositions of a material—in this ...

ByReveal Surgical


Synchron announces first direct-thought tweet, “Hello World,”using an implantable brain computer interface

Synchron announces first direct-thought tweet, “Hello World,”using an implantable brain computer interface

Synchron, a brain computer interface company, today announced a Twitter takeover by Philip O’Keefe, one of the patients implanted with the Stentrode brain computer interface. ...

BySynchron, Inc.


Detecting the previously undetectable

Detecting the previously undetectable

Combining engineering and medicine can lead to world-leading tools like the Raman spectroscopy, which can help to distinguish cancer cells from healthy cells; for example, in brain tumour surgery.ISTOCKPHOTO / GETTY IMAGES One of the biggest challenges in brain tumour surgery is making sure that all cancer cells are removed. ...

ByReveal Surgical


Lixte Biotechnology Holdings, Inc. Announces that enrollment has resumed in national cancer institute’s trial to determine ability of Lixte compound lb-100 to enter recurrent, malignant brain tumors

Lixte Biotechnology Holdings, Inc. Announces that enrollment has resumed in national cancer institute’s trial to determine ability of Lixte compound lb-100 to enter recurrent, malignant brain tumors

(Nasdaq: LIXT) announced that the National Cancer Institute (NCI) has resumed enrolling patients into their pharmacologic study of the ability of Lixte’s lead compound, LB-100, to enter the brain and penetrate recurrent, malignant brain tumors, in patients where surgical removal of their cancer is indicated. ...

ByLIXTE Biotechnology Holdings, Inc.


Made in Quebec: Illuminating hidden brain cancer cells

Made in Quebec: Illuminating hidden brain cancer cells

“Ninety percent of the time the failures are exactly where the surgery stopped,” explains Kevin Petrecca, Chief of the Department of Neurosurgery at the McGill University Health Centre, about those elusive cancer cells. Now, the Montreal-based company that Petrecca helped found is poised to solve the problem of residual brain cancer. Reveal Surgical ...

ByReveal Surgical

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT